Blogs
08/01/2024 admin
As artificial intelligence (AI) continues to reshape healthcare, its significant impact in the field of oncology becomes increasingly noteworthy.
Penn Medicine Princeton Medical Center's (PMC) Center for Digestive Health is at the forefront of this transformation, employing AI to enhance the early detection of elusive precancerous polyps during colonoscopies.
In this article, we discuss the alarming rates of colorectal cancer and the significance of early detection. We also explore holistic approaches to lifestyle habit changes for reducing cancer risk. Lastly, we delve into how VinBrain's DrAid™ MRI Rectal Cancer D&T is becoming a game-changer in cancer diagnostics and treatment.
Colonoscopy remains the gold standard for detecting and preventing colorectal cancer. The integration of AI into this procedure marks a significant leap forward in the field of oncology.
Colorectal cancer stands as one of the most prevalent and preventable forms of cancer in the United States.
Alarming statistics from the American Cancer Society estimated that over 153,000 new cases were diagnosed in the U.S. in 2023, with nearly 53,000 fatalities attributed to the disease.
Disturbingly, the rates of colorectal cancer are on the rise among individuals under the age of 55, experiencing an approximate 2% annual increase since the mid-1990s.
Most cases diagnosed in younger individuals are often in advanced stages, posing significant challenges in treatment.
While researchers delve into the causes of this surge in younger adults, several risk factors, including genetic predisposition, lifestyle choices, and inflammatory bowel diseases, contribute to rectal cancer across all age groups.
Early detection plays a pivotal role in the successful management of colorectal cancer.
Typically originating as polyps or growths in the rectum, these adenomas may remain asymptomatic, making early screening crucial.
The American Cancer Society recommends regular screenings from the age of 45 for those at average risk. Meanwhile, individuals with a family history should commence screenings earlier, following consultation with their healthcare provider.
It is also crucial to identify and see a doctor right away when symptoms occur, which include:
Colonoscopy remains the gold standard for detecting and preventing colorectal cancer. The integration of AI into this procedure marks a significant leap forward in the field of oncology.
At VinBrain, we have created DrAid™ MRI Rectal Cancer D&T, an FDA-approved AI system, for screening and surveillance colonoscopies.
In real-time, the AI-powered platform assists physicians by automatically identifying abnormal lesions in the rectum. DrAid™ MRI Rectal Cancer D&T is also crucial to oncologists’, helping them prepare personalized treatment plans.
And while AI-assisted colonoscopy is trailblazing technology, it's crucial to note that the technology is designed to complement the expertise of well-trained clinicians, aiming to support their decision-making processes.
Clinical trials utilizing DrAid™ MRI Rectal Cancer D&T has shown a 70% decrease in detection time for doctors, and a 70-80% rate of survival when using AI for detection. This underscores the potential of AI in improving the efficacy of cancer screenings and ultimately saving more lives through early detection and intervention.
In addition to embracing technological advancements, individuals can actively reduce their risk of colorectal and other cancers through lifestyle modifications.
Embracing a health-conscious lifestyle with a balanced diet, regular exercise, and avoiding tobacco and excessive alcohol are key factors to preventing cancer. These lifestyle choices not only mitigate the risk of developing cancer but also contribute to overall well-being.
In conclusion, the integration of AI in oncology, particularly in the context of colorectal cancer screening and treatment, represents a groundbreaking advancement. By combining the power of VinBrain's DrAid™ MRI Rectal Cancer D&T with the expertise of healthcare professionals, we stand on the brink of a new era where early detection is more accurate, and treatment outcomes are optimized, offering hope for a future with fewer lives lost to rectal cancer.